Dr Neil Guha

Dr Neil Guha

Clinical Associate Professor in Hepatology

+44 115 924 9924 Ext 70609 View full bio
Queens Medical Centre Campus, Derby Road, Nottingham, NG7 2UH

Dr Neil Guha is a Clinical Associate Professor in Hepatology at the University of Nottingham. He trained at Guy’s and St. Thomas’s hospitals and began his postgraduate career in hepatology at St. Mary’s Hospital, London. His doctoral thesis, awarded by the University of Southampton, focussed on non-invasive biomarkers of liver fibrosis. He completed his clinical training at the Southampton Liver Unit and was appointed as a clinical lecturer by the University of Southampton in 2008. He moved to Nottingham in 2009 to commence his current post at the National Institute of Health Research Nottingham Digestive Diseases Centre Biomedical Research Unit. His research continues to focus on biomarkers of liver fibrosis with current work in serum markers, hypothesis generating technologies, imaging modalities and utilisation of biomarkers in clinical practice.

Publications
Title
Antibiotic prophylaxis in variceal hemorrhage: timing, effectiveness and associated Clostridium diff
The effects of terlipressin and direct portocaval shunting on liver haemodynamics following 80% hepa
Clinically significant chronic liver disease in people with Type 2 diabetes: the Edinburgh Type 2 Di
Back to the Future with Noninvasive Biomarkers of Liver Fibrosis
Antibiotic prophylaxis in variceal hemorrhage: Timing, effectiveness and Clostridium difficile rates
Non-invasive monitoring of liver fibrosis
Consistent Beneficial Effects of Killer Cell Immunoglobulin-Like Receptor 2DL3 and Group 1 Human Leu
Using non-invasive biomarkers to identify hepatic fibrosis in people with type 2 diabetes mellitus:
Biomarkers of Liver Fibrosis: What Lies Beneath the Receiver Operating Characteristic Curve?
Metabolic phenotyping for enhanced mechanistic stratification of chronic hepatitis C-induced liver f
The value of aspartate aminotransferase and alanine aminotransferase in cardiovascular disease risk
Prediction, prevention and management of postresection liver failure
Clinically significant chronic liver disease in people with Type 2 diabetes: the Edinburgh Type 2 Di
Noninvasive Assessment of Liver Fibrosis: Serum Markers, Imaging, and Other Modalities
Enhanced Liver Fibrosis (ELF) test accurately identifies liver fibrosis in patients with chronic hep
gamma-Glutamyltransferase, but not markers of hepatic fibrosis, is associated with cardiovascular di
Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European liver f
Validation of a novel biomarker model for the prediction for non-alcholic steatohepatitis in patient
Performance characteristics of unsedated ultrathin video endoscopy in the assessment of the upper GI
Validation of terminal peptide of procollagen III for the detection and assessment of nonalcoholic s
Performance characteristics of unsedated ultrathin video endoscopy in the assessment of the upper GI
Economic evaluation of a community-based diagnostic pathway to stratify adults for non-alcoholic fat
The effect of prone positioning with surgical bolsters on liver blood flow in healthy volunteers
The Road to a Successful Transjugular Intrahepatic Portosystemic Shunt (Tips) Service: Experience of
The evaluation of portal hypertension using quantitative magnetic resonance imaging (MRI)
Non-invasive assessment of portal hypertension using quantitative magnetic resonance imaging
Direct targeting of risk factors significantly increases the detection of liver cirrhosis in primar
Visual morphometry and three non-invasive markers in the evaluation of liver fibrosis in chronic liv
A study of T1 relaxation time as a measure of liver fibrosis and the influence of confounding histol
The detection of oesophageal varices using a novel, disposable, probe-based transnasal endoscope: a
The detection of oesophageal varices using a novel, disposable, probe-based transnasal endoscope: a